DK1861105T3 - Fremgangsmåde til fremstilling af galanthamin-hydrobromid - Google Patents

Fremgangsmåde til fremstilling af galanthamin-hydrobromid

Info

Publication number
DK1861105T3
DK1861105T3 DK05808194T DK05808194T DK1861105T3 DK 1861105 T3 DK1861105 T3 DK 1861105T3 DK 05808194 T DK05808194 T DK 05808194T DK 05808194 T DK05808194 T DK 05808194T DK 1861105 T3 DK1861105 T3 DK 1861105T3
Authority
DK
Denmark
Prior art keywords
galanthamine
hydrobromide
preparation
butyl
galanthamine hydrobromide
Prior art date
Application number
DK05808194T
Other languages
Danish (da)
English (en)
Inventor
Bruno Gabetta
Enrico Mercalli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1861105T3 publication Critical patent/DK1861105T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DK05808194T 2004-12-17 2005-11-23 Fremgangsmåde til fremstilling af galanthamin-hydrobromid DK1861105T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002413A ITMI20042413A1 (it) 2004-12-17 2004-12-17 Processo per la preparazione di galantamina bromidrato
PCT/EP2005/012521 WO2006063666A1 (en) 2004-12-17 2005-11-23 Process for the preparation of galanthamine hydrobromide

Publications (1)

Publication Number Publication Date
DK1861105T3 true DK1861105T3 (da) 2009-11-16

Family

ID=35784718

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05808194T DK1861105T3 (da) 2004-12-17 2005-11-23 Fremgangsmåde til fremstilling af galanthamin-hydrobromid

Country Status (20)

Country Link
US (1) US8013151B2 (zh)
EP (1) EP1861105B1 (zh)
JP (1) JP5166878B2 (zh)
KR (1) KR101291446B1 (zh)
CN (1) CN101080231B (zh)
AT (1) ATE440607T1 (zh)
AU (1) AU2005315960B2 (zh)
CA (1) CA2592288C (zh)
DE (1) DE602005016308D1 (zh)
DK (1) DK1861105T3 (zh)
ES (1) ES2330127T3 (zh)
HK (1) HK1113306A1 (zh)
IL (1) IL183933A0 (zh)
IT (1) ITMI20042413A1 (zh)
NO (1) NO338724B1 (zh)
PL (1) PL1861105T3 (zh)
PT (1) PT1861105E (zh)
RU (1) RU2387656C2 (zh)
SI (1) SI1861105T1 (zh)
WO (1) WO2006063666A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT507256B1 (de) * 2008-09-04 2010-10-15 Sanochemia Pharmazeutika Ag Verwendung von galanthaminiumbromid zur herstellung von ophthalmischen formulierungen zur glaukombehandlung
US8247405B2 (en) * 2008-12-10 2012-08-21 Conopco, Inc. Skin lightening compositions with acetylcholinesterase inhibitors
CN101787028B (zh) * 2010-01-12 2012-01-04 恩施清江生物工程有限公司 一种从忽地笑中提取加兰他敏的方法
BG110754A (bg) 2010-09-20 2012-03-30 "Ар енд ДИ" ООД Метод и инсталация за екстракция на растителни суровини
BG66818B1 (bg) * 2013-03-07 2019-01-31 Berbee Beheer B. V. Състав на екстракт от hippeastrum papilio за производство на лекарствени средства и хранителни добавки
CN104177368B (zh) * 2014-05-27 2016-06-08 天津梅花医药有限公司 一种氢溴酸加兰他敏化合物、制备方法及其药物组合物
CN103980284B (zh) * 2014-05-30 2016-03-09 天津梅花医药有限公司 一种氢溴酸加兰他敏化合物及其制备方法
CN107462656A (zh) * 2017-07-04 2017-12-12 上海市农业科学院 一种快速检测石蒜科植物中加兰他敏含量的方法
BG67337B1 (bg) 2018-05-23 2021-06-15 Софарма Ад Метод за получаване на пречистен галантамин хидробромид

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB942200A (en) 1959-03-02 1963-11-20 Chimiko Pharmazevtitschen Zd A method of obtaining galanthamine hydrobromide
GB938767A (en) 1961-12-13 1963-10-09 Vni Chimico Pharmatsevtichesky The preparation of galanthamine from the amaryllidaceae and its separation from associated alkaloids
DE19509663A1 (de) * 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
CN1261434C (zh) * 2003-07-28 2006-06-28 浙江一新制药股份有限公司 从石蒜粗提物中分离高纯度加兰他敏的方法
DE102006033591B4 (de) 2006-07-18 2008-10-16 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. Verfahren zur Stabilisierung der Spinnlösung bei der Herstellung von cellulosischen Verbundformkörpern

Also Published As

Publication number Publication date
US8013151B2 (en) 2011-09-06
CA2592288A1 (en) 2006-06-22
NO338724B1 (no) 2016-10-10
HK1113306A1 (en) 2008-10-03
SI1861105T1 (sl) 2009-12-31
DE602005016308D1 (de) 2009-10-08
US20090043092A1 (en) 2009-02-12
KR101291446B1 (ko) 2013-07-30
ATE440607T1 (de) 2009-09-15
PL1861105T3 (pl) 2010-02-26
PT1861105E (pt) 2009-10-22
JP5166878B2 (ja) 2013-03-21
NO20073053L (no) 2007-06-15
CA2592288C (en) 2014-05-06
CN101080231A (zh) 2007-11-28
WO2006063666A1 (en) 2006-06-22
ES2330127T3 (es) 2009-12-04
EP1861105A1 (en) 2007-12-05
RU2007122353A (ru) 2008-12-20
AU2005315960B2 (en) 2012-01-12
ITMI20042413A1 (it) 2005-03-17
CN101080231B (zh) 2010-11-17
EP1861105B1 (en) 2009-08-26
RU2387656C2 (ru) 2010-04-27
AU2005315960A1 (en) 2006-06-22
JP2008524125A (ja) 2008-07-10
IL183933A0 (en) 2007-10-31
KR20070095897A (ko) 2007-10-01

Similar Documents

Publication Publication Date Title
DK1861105T3 (da) Fremgangsmåde til fremstilling af galanthamin-hydrobromid
ECSP066911A (es) Polimorfo cristalino de un acetato de bazedoxifeno
ECSP066910A (es) Polimorfo cristalino de acetato de bazedoxifeno
CO6170356A2 (es) Derivados de piridazina
PE20080070A1 (es) Derivados de indolobenzazepina fusionados a ciclopropilo como inhibidores de la polimerasa ns5b del virus de la hepatitis c
TW200716541A (en) The preparation and use of compounds as protease inhibitors
TW200633979A (en) Method
WO2009018065A3 (en) Novel glucokinase activators and methods of using same
DK2004576T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af terapeutiske forbindelser og sammensætninger, forbindelser og sammensætninger fremstillet dermed og anvendelse deraf
TW200630359A (en) (S)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate
WO2007017585A3 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0412769D0 (en) Organic compounds
WO2009010789A3 (en) Pyrimidine derivatives 934
GEP20084454B (en) Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
EA200700139A1 (ru) Способ отделения и очистки цезия-131 от карбоната бария
NO20085359L (no) Fremgangsmate for fremstilling av renset hydrokinon
NO20064012L (no) Kjemisk prosess
MX2012006513A (es) Compuestos heterociclicos antivirales.
WO2007082262A3 (en) Novel compounds
AR056418A1 (es) Derivados de bencimidazol como 5-ht6, 5-ht2a, metodo para la obtencion del compuesto y el uso para la fabricacion de un mediicamento
DK1907396T3 (da) Fremgangsmåde til fremstilling af 4-beta-amino-4'-demethyl-4-deoxypodophyllotoxin
DE502005004950D1 (de) Verfahren zur herstellung einer lösung von reinem triethylendiamin (teda)
ATE523484T1 (de) Optische lösung a us 3-carbamoylmethyl-5-methyl- hexansäure
DK1501859T3 (da) 17 alfa-fluoralkyl- 11 beta-benzaldoxim-steroider, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse steroider samt deres anvendelse til fremstilling af lægemidler
DK1873152T3 (da) Hidtil ukendt fremgangsmåde til oprensning af Moxonidin